Company Overview and News

5
CenturyLink to Widen Cloud Offerings With Oracle FastConnect

1h zacks
CenturyLink, Inc. (CTL - Free Report) recently announced that it will offer private access to Oracle Cloud with Oracle Cloud Infrastructure FastConnect to provide customers with a network experience that matches their cloud experience. Oracle Cloud is a cloud computing service offered by Oracle Corporation (ORCL - Free Report) . The communications provider’s Cloud Connect Solutions and Oracle's FastConnect service will allow customers to enjoy consistent performance and reliability of a direct and secure connection.
CMTL MU OCLCF CTL ORCL

19
The Story of Salesforce.com (CRM) Stock Sounds Awfully Familiar

2018-07-16 investorplace
From a broad standpoint, the story at Salesforce.com (NYSE:CRM) is pretty simple. The business is hugely attractive. But CRM stock looks overvalued.
SPLK SAP ALGN SQ SHOP MSFT NFLX CRM ORCL ADBE

47
DocuSign: A Tale Of Guidance, Valuation And The Life Of A Category Killer

2018-07-14 seekingalpha
The shares, in the wake of a quarterly earnings release that was well above expectations in terms of revenue growth, bookings and margins, have appreciated significantly from the IPO price.
AMZN DOCU ORCL ADBE

3
Billion-Dollar Unicorns: Is Palantir Losing Valuation?

2018-07-14 seekingalpha
Palantir was expected to go public last year, but declining valuations appear to have deferred that plan.
IBM GSVC MS.PRI MS.PRK MS.PRE MS.PRF MSFT MS.PRG MS MS.PRA ORCL

5
Oracle NetSuite Aids SAM Labs, Media Agencies Boost Business

2018-07-13 zacks
Oracle (ORCL - Free Report) NetSuite has been gaining traction, of late. NetSuite was recently selected by the likes of SAM Labs, an innovative EdTech company and notable boutique media agencies to enhance respective business processes. NetSuite acquisition, completed in 2016, enabled Oracle to penetrate the small and medium-sized business (“SMB”) market segment, where it lacked a strong presence. Moreover, the acquisition aided the company expand its cloud portfolio and gain foothold in the market dominated by Amazon’s (AMZN - Free Report) Amazon Web Services ("AWS") and Microsoft’s (MSFT - Free Report) Azure.
MU MSFT ORCL

2
In the Case of Oracle Stock, Boring Does Not Equal Bad

2018-07-12 investorplace
The solid fourth-quarter results from Oracle Corporation (NYSE:ORCL) put an end to the downside momentum. Even though the company also issued a first-quarter guidance of revenue growing just 1 to 3 percent in the current (first) quarter, favorable valuations and the prospects of the Cloud Services unit will continue drawing investors with a long-term time horizon.
OCLCF MSFT CRM ORCL

40
Should You Buy CRM Stock? 3 Pros, 3 Cons

2018-07-12 investorplace
No matter how you slice it, data is what makes the world go round these days. From the Internet of Things to artificial intelligence and machine learning, everyone is looking for ways to pull, process, store and share data. For that reason, it’s important to beef up your portfolio with a few big data stocks to ensure that you can capitalize on this trend, and there’s no purer data play than salesforce.
AMZN GOOGL OCLCF MSFT GOOG CRM ORCL

3
Tech Companies Jockey as Pentagon Says Cloud Contract Coming - Bloomberg

2018-07-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
IBM OCLCF MSFT ORCL

2
BLOK Technologies Subsidiary Greenstream Networks Joins Oracle Scaleup Ecosystem

2018-07-11 globenewswire
VANCOUVER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- BLOK Technologies Inc. ("BLOK Tech" or the "Company") (CSE:BLK) (FRANKFURT:2AD) is pleased to announce that its 100% owned subsidiary Greenstream Networks Inc. (“Greenstream”) has been accepted into the Oracle Scaleup Ecosystem, a global acceleration program for start-ups.
CCAN ORCL

115
Oakmark Equity And Income Fund: Second Quarter 2018

2018-07-11 seekingalpha
The Equity and Income Fund earned 0.2% in the quarter, while the Lipper Balanced Fund Index, the Fund’s performance benchmark, gained 1.1%.
PM C.WSA DOV.WI NOV TEL CVS FNF BAC C.WS.B CHTR APY.WI GM.WS.A FNFV C.WS.A GM.WS.B GM.WS.C C.PRP DOV C.PRU GM ORCL C.PRS LBRDB BAC C C.PRL AAL C.PRJ C.PRK BHGE COMM MA ARNC C.PRG TWC LBRDK C.PRC BHI C.PRPCL CGBBW OCLCF JLL LBRDA FL APY GM.WSB UNH

1
Oracle's Cloud Strategy Sputters: The Stock Hangs By A Thread, But 1/3rd Of Oracle's Market Cap Is In Cash

2018-07-11 seekingalpha
Oracle (ORCL) reported their fiscal Q4 '18 financial results a few weeks ago and the reaction of the stock price was that it promptly dropped into the $43 - $44 area but fortunately hasn't gone lower.
ORCL

4
PTC's Opportunity In The IoT Market

2018-07-11 seekingalpha
By expanding its portfolio to the IoT space, PTC has strengthen its position with its customers and in the manufacturing market.
PTC SAP CSCO ORCL AR

6
Kavanaugh Made a Mark on Drones and Net Neutrality. What's Next? - Bloomberg

2018-07-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FB GOOGL OCLCF GOOG ORCL

15
Amazon as a Value Stock? Believe It - Bloomberg

2018-07-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
IBM NOBGF UPS BC94 WBA SMSN NFLX CVS N21 OCLCF NOBGY ORCL SMSD

1
Stock Buybacks Are Booming, but Share Prices Aren’t Budging - WSJ

2018-07-09 wsj
U.S. companies are buying back record amounts of stock this year, but their shares aren’t getting the boost they bargained for.
OCLCF ORCL

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

11h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

13h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ORCL / Oracle Corp. on message board site Silicon Investor.

Oracle Corporation (ORCL) Orcl split?
ORCL: Oracle Corporation SLNN, Development partner with ORCL/JAVA
Analyst Bashing (intc orcl mu amat csco) Oracle + Apple =?
Oracle - look out below!!!!
CUSIP: 68389X105